
Seamac India Pharmaceuticals Private Limited
About Seamac India Pharmaceuticals Private Limited
Data last updated:
Seamac India Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 June 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PTC059752. Its GSTIN is 02AAACS3400P1ZN (Himachal Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.37 Lakh. It is led by directors Sudhir Sharma (Managing Director) and Abhishek Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 3 Lgf Lajpat Nagar, New Delhi, Delhi, India – 110024.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.42 Cr, a decline of 51% compared to the previous year. For the same year it recorded a net profit of ₹56,373 (net margin 0.4%) and EBITDA of ₹8.92 Lakh (EBITDA margin 6.3%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 15% over five years.
As per MCA filings, the company has open charges of ₹52.2 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Seamac India Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD – 3 Lgf Lajpat Nagar, New Delhi, Delhi, India – 110024
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Seamac India Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Seamac India Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Seamac India Pharmaceuticals Private Limited, buy the company report.
Financials of Seamac India Pharmaceuticals Private Limited
FY 2025 filings availableSeamac India Pharmaceuticals Private Limited reported revenue of ₹1.42 Cr (down 51% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 51% fall in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹56,373 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.3% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Seamac India Pharmaceuticals Private Limited, buy the company report.
Board of directors of Seamac India Pharmaceuticals Private Limited
Seamac India Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhir Sharma Also directs: Seamac Formulations Private Limited | Managing Director | 22 Jun 1994 | 32 Years 4 Months | Current |
| Abhishek Sharma Also directs: Seamac Formulations Private Limited | Director | 20 Mar 2018 | 8 Years 8 Months | Current |
Auditor
Seamac India Pharmaceuticals Private Limited is audited by KASHYAP SIKDAR & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KASHYAP SIKDAR & CO | FY 2019 | 016253N |
Shareholding
The shareholding of Seamac India Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Seamac India Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Jun 2020 | 100397338 | Others | ₹6.4 Lakh | Open | |
| 21 Aug 1999 | 90035344 | Others | ₹32 Lakh | Open | |
| 24 Nov 1994 | 90033311 | Hrryana Financial Corp. | ₹13.8 Lakh | Open |
To see the full charge records of Seamac India Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Seamac India Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Seamac India Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Seamac India Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAACS3400P1ZN | Himachal Pradesh | Active | 10 Jul 2017 |
To see the full GST registrations and return filing status of Seamac India Pharmaceuticals Private Limited, buy the company report.
Recent activity
Seamac India Pharmaceuticals Private Limited has 3 board changes on record since 1994: 2 appointments and 1 cessation. The latest: Pushpa Pandit ceased to be Director on 21 Mar 2018.
Frequently asked questions
Seamac India Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 June 1994 (32+ years old) and is registered under CIN U74899DL1994PTC059752.
Seamac India Pharmaceuticals has 2 current directors:
- Sudhir Sharma - Managing Director
- Abhishek Sharma - Director
The latest financial statements of Seamac India Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Seamac India Pharmaceuticals is 02AAACS3400P1ZN, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Seamac India Pharmaceuticals is U74899DL1994PTC059752. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Seamac India Pharmaceuticals was incorporated on 22 June 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.
Pushpa Pandit ceased to be Director on 21 Mar 2018. Abhishek Sharma was appointed as Director on 20 Mar 2018. Sudhir Sharma was appointed as Managing Director on 22 Jun 1994.
The registered office of Seamac India Pharmaceuticals is at D – 3 Lgf Lajpat Nagar, New Delhi, Delhi, India – 110024.
Seamac India Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Seamac India Pharmaceuticals has open charges of ₹52.2 Lakh and no satisfied charges on record as per latest MCA filings.

